Nov 17O1,416.00H1,432.28L1,410.00C1,417.66Vol604.3k
Lilly Eli Co stock is traded at $1,416.97, with a volume of 873,258. It is down -1.03% in the last 24 hours and up +12.72% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,431.67
Open:
$1,416.00
24h Volume:
873,258
Relative Volume:
0.27
Market Cap:
$1.26T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
51.01
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
-1.07%
1M Performance:
+12.72%
6M Performance:
+41.00%
1Y Performance:
+38.69%
1-Day Range:
$1,410.00$1,432.28
1-Week Range:
$1,410.00$1,475.25
52-Week Range:
$850.51$1,475.25
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS